| Active substance | Olmesartan |
|---|---|
| Formula | C29H30N6O6 |
| Side effects | Dizziness, headache, diarrhea, abdominal pain, fatigue, hyperkalemia, rare cases of angioedema |
| Effects | Lowers blood pressure, reduces the risk of stroke and heart attack |
| Dosage (sports) | Not applicable |
| Dosage (medical) | Typically starting at 20 mg once daily, can be increased to 40 mg once daily |
| Half-life | Approximately 13 hours |
| Main action | Antihypertensive |
| Substance class | Angiotensin II receptor blocker |
| Chemical name | (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(2-hydroxypropan-2-yl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-1H-imidazole-5-carboxylate |
| Storage conditions | Store at room temperature, protect from moisture and light |
| Trade name | Benicar |
| Blood pressure | Reduces systolic and diastolic blood pressure |
| Also known as | Olmetec |
| Strength | 40mg |
| Lab Test | Monitoring of blood pressure and renal function |
| Hepatotoxicity | Low risk |
| Use in sports | Not commonly used in sports |
| Manufacturer | Helios Pharmaceuticals |
| Packing | 10 tabs/blister |
Olmesmart 40 mg Helios Pharmaceuticals
€36.00
There are no reviews yet.